Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q2 2022
Institutional positions in Verona Pharma plc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +1 vs. Q1 2022
- Shares held
- 35.1M
- −1.34M (−3.7%) vs. Q1 2022
- Total value
- $145.9M
- −$35.9M (−19.7%) vs. Q1 2022
- New holders
- 9
- 6 more added
- Sold out
- 8
- 4 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 5,694,841 | $23.9M | 0.46% | 00.0% | Unchanged |
| NEA Management Company, LLC | 5,108,563 | $21.4M | 1.10% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 5,100,000 | $21.4M | 0.57% | 00.0% | Unchanged |
| Wellington Management Group LLP | 3,828,149 | $16.0M | 0.00% | +49,364+1.3% | Added |
| Perceptive Advisors LLC | 2,915,146 | $12.2M | 0.38% | −129,157−4.2% | Reduced |
| Vivo Capital, LLC | 2,749,918 | $11.5M | 1.16% | 00.0% | Unchanged |
| Abingworth LLP | 2,457,500 | $10.2M | 3.26% | +10.0% | Added |
| Aisling Capital Management LP | 1,332,485 | $5.58M | 3.98% | 00.0% | Unchanged |
| Foresite Capital Management III, LLC | 1,111,112 | $4.66M | 16.89% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,111,112 | $4.66M | 1.25% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 926,602 | $3.88M | 0.89% | 00.0% | Unchanged |
| Novo Holdings A/S | 761,205 | $3.19M | 0.16% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 751,905 | $3.15M | 0.12% | 00.0% | Unchanged |
| Woodline Partners LP | 501,458 | $2.10M | 0.03% | +501,458 | New |
| venBio Partners LLC | 161,897 | $678.0K | 0.19% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 54,300 | $227.0K | 0.00% | −4,100−7.0% | Reduced |
| Ikarian Capital, LLC | 300,000 | $200.0K | 0.08% | +300,000 | New |
| D.A. Davidson & Co. | 44,500 | $186.0K | 0.00% | −3,500−7.3% | Reduced |
| Boothbay Fund Management, LLC | 38,280 | $160.0K | 0.01% | +38,280 | New |
| Renaissance Technologies LLC | 28,200 | $118.0K | 0.00% | +28,200 | New |
| Forefront Analytics, LLC | 27,196 | $112.0K | 0.05% | −8,460−23.7% | Reduced |
| HSBC Holdings PLC | 15,041 | $69.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 14,437 | $60.0K | 0.00% | 00.0% | Unchanged |
| IPG Investment Advisors LLC | 11,900 | $50.0K | 0.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 11,593 | $49.0K | 0.00% | +11,593 | New |
| Citadel Advisors LLC | 10,749 | $45.0K | 0.00% | +10,749 | New |
| Morgan Stanley | 9,785 | $41.0K | 0.00% | +332+3.5% | Added |
| Simplex Trading, LLC | 7,866 | $32.0K | 0.00% | +2,114+36.8% | Added |
| US Bancorp | 3,840 | $16.0K | 0.00% | 00.0% | Unchanged |
| Endurance Wealth Management, Inc. | 2,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,126 | $8.00K | 0.00% | +1,095+106.2% | Added |
| Bank of America Corp | 1,677 | $7.00K | 0.00% | +1,082+181.8% | Added |
| Fifth Third Bancorp | 1,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 892 | $4.00K | 0.00% | 00.0% | Unchanged |
| Brewin Dolphin Ltd | 726 | $3.00K | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 600 | $3.00K | 0.00% | +600 | New |
| Federation des caisses Desjardins du Quebec | 650 | $2.72K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 79 | $0 | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 13 | $0 | 0.00% | +13 | New |
| Larson Financial Group LLC | 25 | $0 | 0.00% | +25 | New |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −750,000−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −666,339−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −369,008−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −26,799−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −18,333−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −13,150−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −655−100.0% | Sold out |